Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
The high-risk nature of the pharmaceutical industry, which relies on the successful launch of new drugs to offset the effects of patent expirations, has made investors increasingly cautious. This caution is evident in the market performance of many big pharma stocks, which have lagged behind the S&P 500 over the past 20 years. However, this underperformance has opened up some potentially attractive investment opportunities. One such opportunity is Bristol Myers Squibb (NYSE: BMY) (BMS), a top-tier U.S. biopharmaceutical company. BMS' shares are currently undervalued based on several valuation metrics, and the company has a strong history of innovation. Additionally, it offers an enticing dividend yield of 4.97%. But how does BMS stock compare to the popular Vanguard S&P 500 ETF (NYSEMKT: VOO) ? This exchange-traded fund (ETF) provides a cost-effective way to invest in 500 of the largest U.S. companies in the market. It's also often used as a benchmark for the U.S. stock market,
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Jumo Health to Lead a Roundtable Discussion on Authenticity and the Patient Voice at the Annual Health Equity in Clinical Trials Congress [Yahoo! Finance]Yahoo! Finance
- Petauri™ Announces 2 Key Hires at Petauri Advisors [Yahoo! Finance]Yahoo! Finance
- Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact [Seeking Alpha]Seeking Alpha
- Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases [Yahoo! Finance]Yahoo! Finance
- Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune DiseasesPR Newswire
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 4/25/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/22/24 - Form DEFA14A
- BMY's page on the SEC website